Видео ютуба по тегу Recursion Pharmaceuticals

Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner
Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner
Recursion Thinks AI Can Lower The High Failure Rate Of New Pharmaceutical Drugs
Recursion Thinks AI Can Lower The High Failure Rate Of New Pharmaceutical Drugs
Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer
Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer
Рекурсия 101: Биотехнологическая компания, занимающаяся разработкой лекарств
Рекурсия 101: Биотехнологическая компания, занимающаяся разработкой лекарств
Is Recursion Pharmaceuticals RXRX Stock a Good Time to Buy Now?
Is Recursion Pharmaceuticals RXRX Stock a Good Time to Buy Now?
Inside the the Most Powerful Supercompuer in Pharma
Inside the the Most Powerful Supercompuer in Pharma
RXRX Stock (Recursion Pharmaceuticals, Inc.) RXRX Stock Analysis | October 8, 2025
RXRX Stock (Recursion Pharmaceuticals, Inc.) RXRX Stock Analysis | October 8, 2025
My Key Takeaway from Recursion Pharmaceuticals' Acquisition Filing
My Key Takeaway from Recursion Pharmaceuticals' Acquisition Filing
RXRX Recursion Pharmaceuticals: Unexplained Surge - Thursday Predicted Opening Price? 5 Signs 🚨
RXRX Recursion Pharmaceuticals: Unexplained Surge - Thursday Predicted Opening Price? 5 Signs 🚨
RXRX: Can AI Transform Drug Discovery and Propel Recursion Pharmaceuticals Forward?
RXRX: Can AI Transform Drug Discovery and Propel Recursion Pharmaceuticals Forward?
POTENTIAL BREAKOUT : RXRX STOCK ANALYSIS | RECURSION PHARMACEUTICALS INC STOCK
POTENTIAL BREAKOUT : RXRX STOCK ANALYSIS | RECURSION PHARMACEUTICALS INC STOCK
Recursion's Chris Gibson on Building a Virtual Cell to Supercharge Drug Discovery
Recursion's Chris Gibson on Building a Virtual Cell to Supercharge Drug Discovery
RXRX Stock (Recursion Pharmaceuticals, Inc.) RXRX Stock Analysis | October 7, 2025
RXRX Stock (Recursion Pharmaceuticals, Inc.) RXRX Stock Analysis | October 7, 2025
Founder Stories: Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals
Founder Stories: Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals
Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024
Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024
RXRX Recursion Pharmaceuticals: Friday Predicted Opening Price - Can It Rebound? 3 Targets 🚨
RXRX Recursion Pharmaceuticals: Friday Predicted Opening Price - Can It Rebound? 3 Targets 🚨
Recursion's (L)earnings Call — 2Q 2025 — August 5, 2025
Recursion's (L)earnings Call — 2Q 2025 — August 5, 2025
New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery
New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery
RXRX Stock Next WEEK CRAZY! (Exact Play Exposed) Recursion Pharmaceuticals best broker review
RXRX Stock Next WEEK CRAZY! (Exact Play Exposed) Recursion Pharmaceuticals best broker review